OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization manufacture of recombinant antibodies in Chinese Hamster Ovary (CHO) cells is a critical step in the development of biopharmaceutical therapeutics. To enhance yield, various strategies are employed, including selection of high-producing cell lines, optimization of culture media components, and implementation of bioreactor technolog